Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Updated the page’s displayed revision version from v3.5.2 to v3.5.3 as part of the site/system release.
    Difference
    0.0%
    Check dated 2026-04-24T16:45:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:36:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Paraganglioma added to conditions; page revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:00:25.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:36.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-02-12T01:53:57.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    New study record dates were added (2026-01-12, 2026-01-29, 2026-01, 2028-12-31). Old dates (2025-07-31, 2025-12-31, 2025-07-29, 2025-07) were removed and the revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T23:38:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.